[Featured Stock] SK Bioscience Rises on Strong Expectations for Second Half Performance
[Asia Economy Reporter Song Hwajeong] SK Bioscience is showing a strong performance with a gain of over 6% due to its solid second-quarter results and expectations for the second half of the year.
As of 9:41 AM on the 2nd, SK Bioscience was trading at 182,000 KRW, up 11,500 KRW (6.74%) from the previous day.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
SK Bioscience recorded second-quarter sales of 144.6 billion KRW, a 277.2% increase compared to the same period last year, and operating profit turned positive at 66.2 billion KRW. The outlook suggests even better performance in the second half. Park Byung-guk, a researcher at NH Investment & Securities, said, "The results will be better in the second half," adding, "Sales from the Novavax government contract for 40 million doses are expected to begin in earnest from the second half."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
